GTx, Inc. announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Jefferies 2018 Global Healthcare Conference.
A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.
About GTx
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious and/or significant unmet medical conditions, including stress urinary incontinence and prostate cancer.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180531005164/en/
Contacts
Investor Contact:
Argot Partners
Kimberly Minarovich or Sam Martin
212-600-1902
or
Media Contact:
Red House Consulting
Denise Powell, 510-703-9491
denise@redhousecomms.com
